Ferriprox Deferiprone


See Medication Guide
  • Inform patients of the risks of developing agranulocytosis and instruct them to immediately interrupt therapy and report to their physician if they experience any symptoms of infection such as fever, sore throat, or flu-like symptoms.
  • Inform patients that the amount of Ferriprox prescribed is based on body weight and on the therapeutic goal (reduction or stabilization of the body iron load).
  • Ferriprox may be taken with or without food. Taking Ferriprox with meals may help reduce nausea.
  • Advise patients to take the first dose of Ferriprox in the morning, the second dose at midday and the third dose in the evening.
  • Counsel patients that if a dose of this medication has been missed, it must be taken as soon as possible. However, if it is almost time for the next dose, skip the missed dose and go back to the regular dosing schedule. Do not catch up or double-dose.
  • Advise patients to allow at least a 4-hour interval between Ferriprox and other medications or supplements containing polyvalent cations such as iron, aluminum or zinc.
  • Advise patients to contact their physician in the event of an overdose.
  • Inform patients that their urine might show a reddish/brown discoloration due to the excretion of the iron-deferiprone complex. This is a very common sign of the desired effect of Ferriprox, and it is not harmful.
  • Counsel women of reproductive potential to avoid pregnancy while taking Ferriprox. Advise patients to immediately notify their physician if they become pregnant or if they plan to become pregnant during therapy.
  • Advise patients to refer to the Ferriprox Oral Solution Medication Guide and Instructions for Use booklet before taking Ferriprox Oral Solution.